Pharma

Pharma

Eli Lilly's Zepbound preferred by physicians: Spherix survey

A Spherix survey of physicians shows that injected weight loss drugs remain favored over newer oral treatments, with Lilly’s Zepbound leading the pack

Kevin Dunleavy Aug 7, 2026 11:36am

Regulatory tracker: TransThera scores key cancer nod in China

Aug 7, 2026 10:45am

Designing an agentic, future‑ready tech roadmap for emerging pharma

Brought to you by ZS

showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts

Aug 7, 2026 10:45am

Pharma marketers face privacy hurdles, turn to omnichannel strategies

Brought to you by Swoop

Novo Nordisk makes Omnicom agency of record for US media buying

Aug 7, 2026 9:44am